# ImpactLife – FDA Inspection, May 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/impactlife/d5bb604a-d2b3-469b-b662-29bee4f85201
Source feed: FDA_Inspections

> FDA inspection 1172085 of ImpactLife, May 18, 2022. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172085
- Company Name: ImpactLife
- Inspection Date: 2022-05-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1259431 - 2025-01-24
- FDA Inspection 1051874 - 2018-04-23
- FDA Inspection 961380 - 2016-02-17
- FDA Inspection 875787 - 2014-04-22
- FDA Inspection 781241 - 2012-05-07

Company: https://www.keypedia.com/companies/impactlife/65ce090d-363c-4bf3-81b8-f71e201e6b2f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d